Company Filing History:
Years Active: 2001-2012
Title: Edward Richard Moxon: Innovator in Vaccine Development
Introduction
Edward Richard Moxon is a notable inventor based in Oxford, GB. He has made significant contributions to the field of vaccine development, holding a total of 3 patents. His work focuses on creating innovative solutions for treating diseases through immunogenic components.
Latest Patents
Moxon's latest patents include a vaccine designed for the treatment of diseases caused by specific serogroups. This vaccine comprises one or more immunogenic components, along with antibodies to these components. The methods outlined in his patents aim to prevent and treat infections effectively. The immunogens utilized in these vaccines are based on elements of the inner core lipopolysaccharide, showcasing Moxon's commitment to advancing medical science.
Career Highlights
Throughout his career, Moxon has worked with prominent organizations, including Isis Innovation Limited and the National Research Council of Canada. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his contributions to vaccine research.
Collaborations
Some of Moxon's notable coworkers include Michael Paul Jennings and Joyce Susan Plested. Their collaborative efforts have played a crucial role in the development of innovative vaccine solutions.
Conclusion
Edward Richard Moxon stands out as a dedicated inventor in the realm of vaccine development. His innovative patents and collaborations reflect his commitment to improving public health through scientific advancements.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.